Vesicular Palmoplantar Eczema

DBCOND0036754Skin and Subcutaneous Tissue Diseases

Vesicular Palmoplantar Eczema is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Eczema, Dyshidrotic · Dyshidrotic eczema · Pompholyx
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0017279SNOMED CT123698008MedDRA10013912UMLSC0032633

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Vesicular Palmoplantar Eczema share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In